IFIH1 and interstitial lung disease: Thus, this retrospective study was conducted to elucidate clinical difference and survival rates of RP-ILD in anti-MDA5 positive and anti-ARS positive patients, to analyze the susceptibility factors of RP-ILD in two groups of patients separately.